arteriosclerotic heart disease
Top stories
Latest
- Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD RiskGlobeNewswire — public companies · 2026-10-01 11:00 UTC · story
- Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupusrenalandurologynews.com · 2026-09-30 13:14 UTC · story